Clinical trial
Novel Nanosensor Array for Detection of Volatile Biomarkers From Skin in Multiple Sclerosis
NCT04074629
Study timeline
Study start (actual)2019-12-16Date precision: day
Registry last updated2022-12-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
Diagnosis, skin volatile organic compounds (VOCs)DIAGNOSTIC_TEST
Sponsors & collaborators
Carmel Medical Centerlead sponsor
Technion, Israel Institute of Technologycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04074629 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.